O-187 Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in Non-Small Cell Lung Cancer (NSCLC) patients after prior chemotherapy
Herbst R, Davies A, Johnson B, Natale R, Dang T, Murren J, Schiller J, Garland L, Miller V, Mendelson D, Melenevsky Y, Devries D, Van Den Abbeele A, Eberhard D, Lyons B, Lutzker S. O-187 Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in Non-Small Cell Lung Cancer (NSCLC) patients after prior chemotherapy. Lung Cancer 2005, 49: s62. DOI: 10.1016/s0169-5002(05)80321-6.Peer-Reviewed Original Research